Galen Partners is a healthcare venture capital firm.
Business Model: B2B
Revenue: $5.5M
Employees: 11-50
Address: 680 Washington Blvd
City: Stamford
State: CT
Zip: 06901
Country: US
Galen has enjoyed a long and successful track record of partnering with experienced and driven management teams to build large, sustainable businesses. Galen achieves this by leveraging healthcare experience and a network of industry relationships to help provide management partners with the necessary resources and support to create and implement impressive growth plans. Since 1990, they have built an investment portfolio with an aggregate market value of over $10 billion–and helped 70 of their portfolio companies navigate through the complicated paths of public offerings, debt financings, and mergers and acquisitions. As such, over the past decade they have gained recognition as one of the largest and most influential names in healthcare private equity investing.
Contact Phone:
+12036536400
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2001 | iScribe | Series D | 15M |
3/2012 | Quotient Biodiagnostics | Venture Round | 0 |
5/2015 | lifeIMAGE | Venture Round | 17.6M |
3/2000 | iScribe | Series B | 21M |
5/2006 | Cardiva Medical | Series C | 0 |
12/2005 | Aperio Technologies | Venture Round | 12M |
9/2002 | Specialized Health Products International | Venture Round | 5M |
9/2015 | lifeIMAGE | Series D | 0 |
6/2000 | EduNeering | Venture Round | - |
11/1999 | More.com | Series C | 43M |
7/2007 | ONI Medical Systems, Inc. | Post-IPO Equity | 12.5M |
2/2008 | Dakim | Venture Round | 10.6M |
1/2009 | Pet DRx | Convertible Note | 6.5M |
2/2013 | Quotient Biodiagnostics | Venture Round | 0 |
10/2012 | Tactile Medical | Series B | 10.4M |
11/2004 | JDS Pharmaceuticals LLC. | Series A | 0 |
4/2016 | Cambrooke Therapeutics | Series C | - |
3/2008 | Aperio Technologies | Series C | 20M |
9/2005 | InTouch Health | Series C | 0 |
5/2007 | Aperio Technologies | Series C | 10.6M |
1/2012 | Sharecare | Venture Round | 0 |
4/2013 | lifeIMAGE | Series C | 15.2M |
5/2008 | Cardiva Medical | Series D | 0 |
8/2003 | ONI Medical Systems, Inc. | Post-IPO Equity | 0 |
8/2012 | Cardiva Medical | Venture Round | - |
4/2011 | Cardiva Medical | Venture Round | 0 |
10/2007 | Tactile Medical | Series A | 11.8M |
4/2016 | Cambrooke Therapeutics | Series C | - |
9/2015 | lifeIMAGE | Series D | 0 |
5/2015 | lifeIMAGE | Venture Round | 0 |
4/2013 | lifeIMAGE | Series C | 0 |
2/2013 | Quotient Biodiagnostics | Venture Round | 0 |
10/2012 | Tactile Medical | Series B | 0 |
8/2012 | Cardiva Medical | Venture Round | - |
3/2012 | Quotient Biodiagnostics | Venture Round | 0 |
1/2012 | Sharecare | Venture Round | 0 |
4/2011 | Cardiva Medical | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|